CNVIF
Conavi Medical Corp. focuses on designing, manufacturing, and marketing imaging technologies to guide common minimally invasive cardiovascular procedures. It offers Novasight Hybrid System, a system that combines intravascular ultrasound and optical coherence tomography to enable simultaneous and co-registered imaging of coronary arteries. Conavi Medical Corp. is based in Toronto, Canada.
Market Cap & Net Worth: CNVIF (CNVIF)
CNVIF (OTCQB:CNVIF) has a market capitalization of $40.07 Million ($40.07 Million) as of March 19, 2026. Listed on the OTCQB stock exchange, this USA-based company holds position #24154 globally and #8383 in its home market, demonstrating a 10.71% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying CNVIF's stock price $0.39 by its total outstanding shares 103416756 (103.42 Million).
CNVIF Market Cap History: 2025 to 2025
CNVIF's market capitalization history from 2025 to 2025. Data shows growth from $40.07 Million to $40.07 Million (0.00% CAGR).
CNVIF Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how CNVIF's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
4.39x
CNVIF's market cap is 4.39 times its annual revenue
0.67x
Higher than industry averageLatest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2025 | $40.07 Million | $9.12 Million | -$20.52 Million | 4.39x | N/A |
Competitor Companies of CNVIF by Market Capitalization
Companies near CNVIF in the global market cap rankings as of March 19, 2026.
Key companies related to CNVIF by market ranking:
- Abbott Laboratories (NYSE:ABT): Ranked #78 globally with a market cap of $191.37 Billion USD.
- Stryker Corporation (NYSE:SYK): Ranked #154 globally with a market cap of $121.03 Billion USD.
- Medtronic PLC (NYSE:MDT): Ranked #168 globally with a market cap of $113.17 Billion USD.
- Boston Scientific Corp (NYSE:BSX): Ranked #185 globally with a market cap of $105.26 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #78 | Abbott Laboratories | NYSE:ABT | $191.37 Billion | $110.71 |
| #154 | Stryker Corporation | NYSE:SYK | $121.03 Billion | $349.11 |
| #168 | Medtronic PLC | NYSE:MDT | $113.17 Billion | $88.44 |
| #185 | Boston Scientific Corp | NYSE:BSX | $105.26 Billion | $71.20 |
CNVIF Historical Marketcap From 2025 to 2025
Between 2025 and today, CNVIF's market cap moved from $40.07 Million to $ 40.07 Million, with a yearly change of 0.00%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2025 | $40.07 Million | -- |
End of Day Market Cap According to Different Sources
On Mar 18th, 2026 the market cap of CNVIF was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $40.07 Million USD |
| MoneyControl | $40.07 Million USD |
| MarketWatch | $40.07 Million USD |
| marketcap.company | $40.07 Million USD |
| Reuters | $40.07 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.